BYU iGEM/Safety

From 2011.igem.org

(Difference between revisions)

Latest revision as of 23:14, 28 September 2011

Team BYU Provo

Home
Team
Project
Results
Protocols
Parts Submitted
Modeling
Safety
Attributions
Notebooks:
- Team OxyR:
  - The Beginning
  - Week 1
  - Week 2
  - Week 3
  - Week 4
  - Week 5
  - Week 6
  - Week 7
  - Week 8
  - Week 9
  - Week 10
  - Week 11
  - Week 12
  - Week 13
  - Week 14
  - Week 15
  - Week 16
  - Week 17
  - Week 18
  - Week 19
  - Week 20
  - Week 21
  - Week 22
  - Week 23
  - Week 24
  - Week 25
  - Week 26
  - Week 27
  - Week 28
- Team Thermosensor:
  - The Beginning
  - Week 1
  - Week 2
  - Week 3
  - Week 4
  - Week 5
  - Week 6
  - Week 7
  - Week 8
  - Week 9
  - Week 10
  - Week 11
  - Week 12
  - Week 13
  - Week 14
  - Week 15
  - Week 16
  - Week 17
  - Week 18
  - Week 19
  - Week 20
  - Week 21
  - Week 22
  - Week 23
  - Week 24
Indiana Trip
Outreach

1. Would the materials used in your project and/or your final product pose:

Risks to the safety and health of team members or others in the lab?

Risks to the safety and health of the general public if released by design or accident?

Risks to environmental quality if released by design or accident?

Risks to security through malicious misuse by individuals, groups or states?

1) As with anything worth pursuing, our project has some necessary risks. In the lab, the main concern is Ethidium Bromide (EtBr), which is a suspected DNA mutagen. We use EtBr in DNA gel electrophoresis to locate the DNA on the gel. Any harmful effects of EtBr may be avoided by wearing gloves and avoiding inhaling the fumes. To prevent the misuse of the EtBr, we only have a small bottle and it is kept behind locked doors as approved by BYU. Once we are finished with the gels that contain EtBr, we discard them in waste bins designated for such gels and the BYU Hazardous Waste team disposes of them as appropriate. All of the other parts, bacteria (E. coli) and instruments that we use in our lab are harmless to humans and the environment under normal conditions.

2. If your response to any of the questions above is yes:

a. Explain how you addressed these issues in project design and while conducting laboratory work.

See answer for question 1.

b. Describe and document safety, security, health and/or environmental issues as you submit your parts to the Registry.

3. Under what biosafety provisions will/do you operate?

All bacteria we work with are BSL level 1. We are expressing a riboswitch from Lysteria on plasmid, however it is simply a riboswitch (no protein from Lysteria is expressed). This riboswitch was synthesized and thus no Lysteria was used in the laboratory.

a. Does your institution have its own biosafety rules and if so what are they? Provide a link to them online if possible.

We operate under the rules and guidelines as outlined on the BYU Life Science’s Safety Page: http://lifesciences.byu.edu/safety/Home.aspx. Also, an IBC application must be filled out for recombinant DNA. We have filed out this IBC report and our project has been approved by Edwin Jackson, the Research Safety Officer of the BYU Biosafety Committee. http://orca.byu.edu/IBC/IBCOverview.aspx

b. Does your institution have an Institutional Biosafety Committee or equivalent group? If yes, have you discussed your project with them?

Yes, see answer for a.

Describe any concerns or changes that were made based on this review.

No changes were made.

c. Will / did you receive any biosafety and/or lab training before beginning your project? If so, describe this training.

Each team member individually read through and passed the BYU Life Sciences Safety and Compliance online training as discussed here: https://lifesciences.byu.edu/safety/LabSafety/SafetyTrainingSecure.aspx; or completed and passed the lab safety training developed by Coastal Technologies Training Corp. and titled "Lab Safety: The Finer Points" offered through the BYU Harold B. Lee Library. For information on the latter, see: http://www.coastal.co.in/site/index.php?option=com_content&task=view&id=36&Itemid=63.

d. Does your country have national biosafety regulations or guidelines? If so, provide a link to them online if possible.

Yes: http://www.cdc.gov/biosafety/

4. OPTIONAL QUESTION: Do you have other ideas on how to deal with safety or security issues that could be useful for future iGEM competitions? How could parts, devices and systems be made even safer through biosafety engineering?

A podcast that you can download with any safety concerns for a particular part that may be considered “risky.”

@@ Line 1: / Line 1: @@
-{{Template:BYU_Provo}}
+__NOTOC__{{Template:BYU_Provo}}<div id='pageContents'>
+<html><script>
+  var ele = document.getElementById('liSafety');
+  ele.style.fontWeight = "bold";
+  ele.style.backgroundColor = "#059469";
+</script></html>
+==1. Would the materials used in your project and/or your final product pose:==
-==Safety==
+* Risks to the safety and health of team members or others in the lab?
+* Risks to the safety and health of the general public if released by design or accident?
-.Would any of your project ideas raise safety issues in terms of:
+* Risks to environmental quality if released by design or accident?
-*researcher safety,
-*public safety, or
+* Risks to security through malicious misuse by individuals, groups or states?
-*environmental safety?
-.Do any of the new BioBrick parts (or devices) that you made this year raise any safety issues? If yes,
+[[File:Doctor E.png|left|The Doctor]]
-*did you document these issues in the Registry?
+) As with anything worth pursuing, our project has some necessary risks.  In the lab, the main concern is Ethidium Bromide (EtBr), which is a suspected DNA mutagen.  We use EtBr in DNA gel electrophoresis to locate the DNA on the gel. Any harmful effects of EtBr may be avoided by wearing gloves and avoiding inhaling the fumes.  To prevent the misuse of the EtBr, we only have a small bottle and it is kept behind locked doors as approved by BYU.  Once we are finished with the gels that contain EtBr, we discard them in waste bins designated for such gels and the BYU Hazardous Waste team disposes of them as appropriate.
-*how did you manage to handle the safety issue?
+All of the other parts, bacteria (E. coli) and instruments that we use in our lab are harmless to humans and the environment under normal conditions.
-*How could other teams learn from your experience?
-.Is there a local biosafety group, committee, or review board at your institution?
+==2. If your response to any of the questions above is yes:==
-*If yes, what does your local biosafety group think about your project?
-*If no, which specific biosafety rules or guidelines do you have to consider in your country?
+===a. Explain how you addressed these issues in project design and while conducting laboratory work.===
-.Do you have any other ideas how to deal with safety issues that could be useful for future iGEM competitions? How could parts, devices and systems be made even safer through biosafety engineering?
+See answer for question 1.
+===b. Describe and document safety, security, health and/or environmental issues as you submit your parts to the Registry.===
+==3. Under what biosafety provisions will/do you operate?==
+All bacteria we work with are BSL level 1.  We are expressing a riboswitch from Lysteria on plasmid, however it is simply a riboswitch (no protein from Lysteria is expressed).  This riboswitch was synthesized and thus no Lysteria was used in the laboratory.
+===a. Does your institution have its own biosafety rules and if so what are they? Provide a link to them online if possible.===
+We operate under the rules and guidelines as outlined on the BYU Life Science’s  Safety Page: http://lifesciences.byu.edu/safety/Home.aspx.  Also, an IBC application must be filled out for recombinant DNA.  We have filed out this IBC report and our project has been approved by Edwin Jackson, the Research Safety Officer of the BYU Biosafety Committee.  http://orca.byu.edu/IBC/IBCOverview.aspx
+===b. Does your institution have an Institutional Biosafety Committee or equivalent group? If yes, have you discussed your project with them?===
+Yes, see answer for a.
+===Describe any concerns or changes that were made based on this review.===
+No changes were made.
+===c. Will / did you receive any biosafety and/or lab training before beginning your project? If so, describe this training.===
+Each team member individually read through and passed the BYU Life Sciences Safety and Compliance online training as discussed here: https://lifesciences.byu.edu/safety/LabSafety/SafetyTrainingSecure.aspx; or completed and passed the lab safety training developed by Coastal Technologies Training Corp. and titled "Lab Safety: The Finer Points" offered through the BYU Harold B. Lee Library. For information on the latter, see: http://www.coastal.co.in/site/index.php?option=com_content&task=view&id=36&Itemid=63.
+===d. Does your country have national biosafety regulations or guidelines? If so, provide a link to them online if possible.===
+Yes: http://www.cdc.gov/biosafety/
+==4. OPTIONAL QUESTION: Do you have other ideas on how to deal with safety or security issues that could be useful for future iGEM competitions? How could parts, devices and systems be made even safer through biosafety engineering?==
+A podcast that you can download with any safety concerns for a particular part that may be considered “risky.”
+</div>